Literature DB >> 17643102

Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes.

Celia M Kassmann1, Corinna Lappe-Siefke, Myriam Baes, Britta Brügger, Alexander Mildner, Hauke B Werner, Oliver Natt, Thomas Michaelis, Marco Prinz, Jens Frahm, Klaus-Armin Nave.   

Abstract

Oligodendrocytes myelinate axons for rapid impulse conduction and contribute to normal axonal functions in the central nervous system. In multiple sclerosis, demyelination is caused by autoimmune attacks, but the role of oligodendroglial cells in disease progression and axon degeneration is unclear. Here we show that oligodendrocytes harbor peroxisomes whose function is essential for maintaining white matter tracts throughout adult life. By selectively inactivating the import factor PEX5 in myelinating glia, we generated mutant mice that developed normally, but within several months showed ataxia, tremor and premature death. Absence of functional peroxisomes from oligodendrocytes caused widespread axonal degeneration and progressive subcortical demyelination, but did not interfere with glial survival. Moreover, it caused a strong proinflammatory milieu and, unexpectedly, the infiltration of B and activated CD8+ T cells into brain lesions. We conclude that peroxisomes provide oligodendrocytes with an essential neuroprotective function against axon degeneration and neuroinflammation, which is relevant for human demyelinating diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17643102     DOI: 10.1038/ng2070

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  114 in total

Review 1.  The peroxisome: an update on mysteries.

Authors:  Markus Islinger; Sandra Grille; H Dariush Fahimi; Michael Schrader
Journal:  Histochem Cell Biol       Date:  2012-03-14       Impact factor: 4.304

2.  Peroxisomes, oxidative stress, and inflammation.

Authors:  Stanley R Terlecky; Laura J Terlecky; Courtney R Giordano
Journal:  World J Biol Chem       Date:  2012-05-26

3.  Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity.

Authors:  Ursula Fünfschilling; Lotti M Supplie; Don Mahad; Susann Boretius; Aiman S Saab; Julia Edgar; Bastian G Brinkmann; Celia M Kassmann; Iva D Tzvetanova; Wiebke Möbius; Francisca Diaz; Dies Meijer; Ueli Suter; Bernd Hamprecht; Michael W Sereda; Carlos T Moraes; Jens Frahm; Sandra Goebbels; Klaus-Armin Nave
Journal:  Nature       Date:  2012-04-29       Impact factor: 49.962

Review 4.  Myelination and support of axonal integrity by glia.

Authors:  Klaus-Armin Nave
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

Review 5.  The emerging role of microRNAs in multiple sclerosis.

Authors:  Andreas Junker; Reinhard Hohlfeld; Edgar Meinl
Journal:  Nat Rev Neurol       Date:  2010-12-14       Impact factor: 42.937

Review 6.  Organelle dynamics and dysfunction: A closer link between peroxisomes and mitochondria.

Authors:  F Camões; N A Bonekamp; H K Delille; M Schrader
Journal:  J Inherit Metab Dis       Date:  2008-12-12       Impact factor: 4.982

7.  PPARα activation induces N(ε)-Lys-acetylation of rat liver peroxisomal multifunctional enzyme type 1.

Authors:  Miguel A Contreras; Oscar Alzate; Avtar K Singh; Inderjit Singh
Journal:  Lipids       Date:  2013-10-05       Impact factor: 1.880

Review 8.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

Review 9.  Peroxisomal dysfunction in inflammatory childhood white matter disorders: an unexpected contributor to neuropathology.

Authors:  Inderjit Singh; Avtar K Singh; Miguel A Contreras
Journal:  J Child Neurol       Date:  2009-07-15       Impact factor: 1.987

10.  Modulation of peroxisome proliferator-activated receptor-alpha activity by N-acetyl cysteine attenuates inhibition of oligodendrocyte development in lipopolysaccharide stimulated mixed glial cultures.

Authors:  Manjeet K Paintlia; Ajaib S Paintlia; Mushfiquddin Khan; Inderjit Singh; Avtar K Singh
Journal:  J Neurochem       Date:  2008-01-12       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.